vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and Medalist Diversified REIT, Inc. (MDRR). Click either name above to swap in a different company.

COMPUGEN LTD is the larger business by last-quarter revenue ($3.5M vs $2.8M, roughly 1.3× Medalist Diversified REIT, Inc.). Medalist Diversified REIT, Inc. runs the higher net margin — -18.8% vs -410.1%, a 391.4% gap on every dollar of revenue. On growth, Medalist Diversified REIT, Inc. posted the faster year-over-year revenue change (11.8% vs -61.8%). Medalist Diversified REIT, Inc. produced more free cash flow last quarter ($77.0K vs $-18.8M).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Medalist Diversified REIT, Inc. is a publicly traded real estate investment trust focused on owning, operating, and acquiring income-generating multi-family residential properties. Its portfolio is concentrated in high-growth US Southeast and Mid-Atlantic markets, targeting stable long-term returns for shareholders via rental income and property appreciation.

CGEN vs MDRR — Head-to-Head

Bigger by revenue
CGEN
CGEN
1.3× larger
CGEN
$3.5M
$2.8M
MDRR
Growing faster (revenue YoY)
MDRR
MDRR
+73.6% gap
MDRR
11.8%
-61.8%
CGEN
Higher net margin
MDRR
MDRR
391.4% more per $
MDRR
-18.8%
-410.1%
CGEN
More free cash flow
MDRR
MDRR
$18.9M more FCF
MDRR
$77.0K
$-18.8M
CGEN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CGEN
CGEN
MDRR
MDRR
Revenue
$3.5M
$2.8M
Net Profit
$-14.5M
$-529.6K
Gross Margin
Operating Margin
-475.1%
14.8%
Net Margin
-410.1%
-18.8%
Revenue YoY
-61.8%
11.8%
Net Profit YoY
-54.7%
-88.4%
EPS (diluted)
$-0.16
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
MDRR
MDRR
Q4 25
$2.8M
Q3 25
$2.8M
Q2 25
$3.5M
$2.5M
Q1 25
$2.3M
Q4 24
$2.5M
Q3 24
$2.3M
Q2 24
$9.3M
$2.3M
Q1 24
$2.6M
$2.6M
Net Profit
CGEN
CGEN
MDRR
MDRR
Q4 25
$-529.6K
Q3 25
$-395.9K
Q2 25
$-14.5M
$-456.4K
Q1 25
$-1.0M
Q4 24
$-281.2K
Q3 24
$-527.0K
Q2 24
$-9.4M
$-521.7K
Q1 24
$7.3M
$1.4M
Gross Margin
CGEN
CGEN
MDRR
MDRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
60.5%
Q1 24
17.9%
Operating Margin
CGEN
CGEN
MDRR
MDRR
Q4 25
14.8%
Q3 25
15.8%
Q2 25
-475.1%
9.8%
Q1 25
-23.8%
Q4 24
17.7%
Q3 24
13.0%
Q2 24
-128.5%
9.4%
Q1 24
Net Margin
CGEN
CGEN
MDRR
MDRR
Q4 25
-18.8%
Q3 25
-14.2%
Q2 25
-410.1%
-18.5%
Q1 25
-43.4%
Q4 24
-11.1%
Q3 24
-22.6%
Q2 24
-101.4%
-22.7%
Q1 24
284.0%
52.8%
EPS (diluted)
CGEN
CGEN
MDRR
MDRR
Q4 25
$-0.49
Q3 25
$-0.33
Q2 25
$-0.16
$-0.34
Q1 25
$-0.74
Q4 24
$-0.24
Q3 24
$-0.47
Q2 24
$-0.10
$-0.47
Q1 24
$89505618.00
$1.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
MDRR
MDRR
Cash + ST InvestmentsLiquidity on hand
$35.3M
$2.6M
Total DebtLower is stronger
$51.4M
Stockholders' EquityBook value
$50.3M
$9.4M
Total Assets
$106.5M
$77.7M
Debt / EquityLower = less leverage
5.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
MDRR
MDRR
Q4 25
$2.6M
Q3 25
$1.9M
Q2 25
$35.3M
$2.0M
Q1 25
$2.7M
Q4 24
$4.8M
Q3 24
$3.1M
Q2 24
$44.6M
$3.8M
Q1 24
$39.3M
$3.6M
Total Debt
CGEN
CGEN
MDRR
MDRR
Q4 25
$51.4M
Q3 25
$63.6M
Q2 25
$49.6M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CGEN
CGEN
MDRR
MDRR
Q4 25
$9.4M
Q3 25
$10.4M
Q2 25
$50.3M
$13.4M
Q1 25
$14.0M
Q4 24
$15.0M
Q3 24
$12.6M
Q2 24
$58.3M
$13.2M
Q1 24
$65.6M
$13.7M
Total Assets
CGEN
CGEN
MDRR
MDRR
Q4 25
$77.7M
Q3 25
$92.1M
Q2 25
$106.5M
$77.7M
Q1 25
$78.2M
Q4 24
$75.1M
Q3 24
$74.6M
Q2 24
$110.2M
$75.2M
Q1 24
$121.3M
$76.0M
Debt / Equity
CGEN
CGEN
MDRR
MDRR
Q4 25
5.45×
Q3 25
6.13×
Q2 25
3.70×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
MDRR
MDRR
Operating Cash FlowLast quarter
$-18.6M
$1.5M
Free Cash FlowOCF − Capex
$-18.8M
$77.0K
FCF MarginFCF / Revenue
-530.8%
2.7%
Capex IntensityCapex / Revenue
6.5%
51.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
MDRR
MDRR
Q4 25
$1.5M
Q3 25
$1.6M
Q2 25
$-18.6M
$244.1K
Q1 25
$460.0K
Q4 24
$1.8M
Q3 24
$139.9K
Q2 24
$39.7M
$778.6K
Q1 24
$492.4K
Free Cash Flow
CGEN
CGEN
MDRR
MDRR
Q4 25
$77.0K
Q3 25
$1000.0K
Q2 25
$-18.8M
$-181.5K
Q1 25
$322.4K
Q4 24
$893.7K
Q3 24
$-164.7K
Q2 24
$39.7M
$645.6K
Q1 24
$265.8K
FCF Margin
CGEN
CGEN
MDRR
MDRR
Q4 25
2.7%
Q3 25
35.9%
Q2 25
-530.8%
-7.4%
Q1 25
13.9%
Q4 24
35.4%
Q3 24
-7.0%
Q2 24
428.3%
28.1%
Q1 24
10.3%
Capex Intensity
CGEN
CGEN
MDRR
MDRR
Q4 25
51.5%
Q3 25
20.4%
Q2 25
6.5%
17.3%
Q1 25
5.9%
Q4 24
35.7%
Q3 24
13.0%
Q2 24
0.4%
5.8%
Q1 24
8.8%
Cash Conversion
CGEN
CGEN
MDRR
MDRR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGEN
CGEN

Segment breakdown not available.

MDRR
MDRR

Retail Center Properties$1.6M58%
Other$1.2M42%

Related Comparisons